Cold Spring Harbor Labs Buys Illumina Oligos for RNAi Research | GenomeWeb

NEW YORK, Dec. 2 - Illumina said today it will sell Cold Spring Harbor Labs roughly 100,000 oligos to help it uncover the mechanism of RNAi.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.